Terms: = Head and neck cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
52 results:
1. [Efficacy and safety of endoscopic submucosal dissection with additional radiotherapy for T1a-MM/T1b-SM esophageal squamous cell carcinoma].
Chen YF; Liu SQ; Li MY; Chen R; Shi RH
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3676-3682. PubMed ID: 38018068
[No Abstract] [Full Text] [Related]
2. Travel-associated cost savings to patients and the health system through provision of specialist head and neck surgery outreach clinics in rural New South Wales, Australia.
Venchiarutti RL; Pearce A; Mathers L; Dawson T; Ch'ng S; Shannon K; Clark JR; Palme CE
Aust J Rural Health; 2023 Oct; 31(5):932-943. PubMed ID: 37501345
[TBL] [Abstract] [Full Text] [Related]
3. Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan.
Kashiwa M
Eur J Health Econ; 2024 Apr; 25(3):459-470. PubMed ID: 37261572
[TBL] [Abstract] [Full Text] [Related]
4. The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours.
Bossi P; Orlandi E; Resteghini C; Vischioni B; Nicolai P; Castelnuovo P; Gambazza S; Locati LD; Turri-Zanoni M; Ferrari M; Facchinetti N; Iacovelli NA; Calareso G; Quattrone P; Cavallo A; Tuzi A; Licitra L
Eur J Cancer; 2023 Jul; 187():134-143. PubMed ID: 37163806
[TBL] [Abstract] [Full Text] [Related]
5. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
6. [Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].
Xu J; Zhang L; Dong W; Chen X; Zhou H; Yin M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 36(12):902-909. PubMed ID: 36543396
[No Abstract] [Full Text] [Related]
7. Institutionally validated nomogram predicting prognosis for older patients with nonmetastatic nasopharyngeal carcinoma.
Yan C; Tu Z; Zhang Z; Ouyang X; Li D; Peng S; Zhong J
Future Oncol; 2022 May; 18(15):1829-1838. PubMed ID: 35179075
[TBL] [Abstract] [Full Text] [Related]
8. Feasibility of a snowball sampling survey to study active surveillance for thyroid microcarcinoma treatment among endocrinologists and surgeons of Brazil.
Silva IMD; Nogueira TQDS; Couto DN; Lima PCTM; Bonfim NSC; Sousa IGV; Telles ACT; Hecht F; Alkmim NR; Penna GCE; Ferraz C; Tomimori E; Ramos HE
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S163-S169. PubMed ID: 35177356
[TBL] [Abstract] [Full Text] [Related]
9. Redefining Perineural Invasion in head and neck Cutaneous Squamous Cell Carcinoma.
Cohen ER; Misztal C; Dable C; Gomez-Fernandez C; Bhatia RG; Roth P; Ma R; Trosman S; Green C; Nicolli E; Dinh CT; Sargi ZB
Otolaryngol Head Neck Surg; 2022 Oct; 167(4):705-715. PubMed ID: 35133896
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
11. Secretory Carcinoma of the Salivary Gland - Systematic Review of the Literature and Report of 2 Cases.
Silver E; Lazow SK; Peters SM; Solomon M; Yusupov S
J Oral Maxillofac Surg; 2022 Jan; 80(1):101-112. PubMed ID: 34653372
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors for local recurrence of early bilateral vocal cord carcinoma treated with transoral CO
Tan C; Fang J; Wang R; Zhong Q; Hou L; Ma H; Feng L; He S; Lian M; Yang Y
Acta Otolaryngol; 2021 Sep; 141(9):860-864. PubMed ID: 34565304
[TBL] [Abstract] [Full Text] [Related]
13. The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
Minakata M; Ito M; Kishi T; Hada M; Masaki Y; Nakamura T; Kousaka K; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2022 Feb; 69(2):165-172. PubMed ID: 34526424
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
Gürbüz M; Doğan İ; Akkuş E; Ermiş H; Utkan G; Vatansever S; Taş F
Dermatol Ther; 2021 Nov; 34(6):e15122. PubMed ID: 34478210
[TBL] [Abstract] [Full Text] [Related]
15. Out-of-pocket costs associated with head and neck cancer treatment.
Khan MN; Hueniken K; Manojlovic-Kolarski M; Eng L; Mirshams M; Khan K; Simpson C; Au M; Liu G; Xu W; Longo CJ; Goldstein DP; Ringash J; Martino R; Hansen AR; de Almeida JR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1528. PubMed ID: 34428351
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic Features, treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis.
Panneerselvam K; Amin RN; Wei D; Tan D; Lum PJ; Zhang HC; Richards DM; Altan M; Grivas P; Thompson JA; Thomas AS; Wang Y
J Natl Compr Canc Netw; 2021 Jun; 19(8):896-904. PubMed ID: 34102607
[TBL] [Abstract] [Full Text] [Related]
17. Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma.
Verma T; Kumari S; Mishra S; Rastogi M; Tiwari V; Agarwal GR; Anand N; Husain N
Indian J Pathol Microbiol; 2020; 63(4):521-526. PubMed ID: 33154299
[TBL] [Abstract] [Full Text] [Related]
18. Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
Porto AC; Pinto Blumetti T; Oliveira Santos Filho IDA; Calsavara VF; Duprat Neto JP; Tavoloni Braga JC
PLoS One; 2020; 15(10):e0240864. PubMed ID: 33095773
[TBL] [Abstract] [Full Text] [Related]
19. Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
Mané M; Benkhaled S; Dragan T; Paesmans M; Beauvois S; Lalami Y; Szturz P; Gaye PM; Vermorken JB; Van Gestel D
Oncologist; 2021 Jan; 26(1):e130-e141. PubMed ID: 32924198
[TBL] [Abstract] [Full Text] [Related]
20. Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance.
Cheng SP; Lee JJ; Chien MN; Kuo CY; Jhuang JY; Liu CL
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1814-1819. PubMed ID: 32732093
[TBL] [Abstract] [Full Text] [Related]
[Next]
